Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Levomepromazine hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Levomepromazine 25mg/1ml solution for injection ampoules
0402010L0AAAAAA
|
Levomepromazine hydrochloride | Levomepromazine hydrochloride | Central Nervous System | 36,557 |
|
Nozinan 25mg/1ml solution for injection ampoules
0402010L0BBAAAA
|
Nozinan (Parenteral) | Levomepromazine hydrochloride | Central Nervous System | 144 |
|
Levomepromazine hydrochloride 25mg/5ml soln sugar free
0402010L0AAAEAE
|
Levomepromazine hydrochloride | Levomepromazine hydrochloride | Central Nervous System | 140 |
|
Levorol 5mg/ml oral solution
0402010L0BCAAAE
|
Levorol (hydrochloride) | Levomepromazine hydrochloride | Central Nervous System | 17 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.